Introduction Dexcel Pharma is a major pharmaceutical corporation based in Israel, established in 1968. The company specializes in creating, producing, and distributing branded and generic pharmaceuticals that offer additional benefits. Their extensive product line includes many branded and generic items available in different dosage forms. |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 3 |
Top 5 Target | Count |
---|---|
Proton pump | 2 |
GR(Glucocorticoid receptor) | 1 |
Target |
Mechanism Proton pump inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date20 Feb 2001 |
Target |
Mechanism Proton pump inhibitors |
Active Org. |
Originator Org. |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date02 Oct 1992 |
Target |
Mechanism Proton pump inhibitors |
Active Org. |
Originator Org. |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date31 Dec 1988 |
Start Date01 Jul 2014 |
Sponsor / Collaborator |
Start Date01 Jan 2011 |
Sponsor / Collaborator Meir Medical Center [+1] |
Start Date01 Dec 2010 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Lansoprazole ( Proton pump ) | Heartburn More | Approved |
Dexamethasone ( GR ) | Multiple Myeloma More | Approved |
Omeprazole ( Proton pump ) | Heartburn More | Approved |
Chlorhexidine gluconate | Periodontitis More | Withdrawn |
Esomeprazole Magnesium ( Proton pump ) | Heartburn More | Withdrawn |